American Society of Clinical Oncology

SHERPA: White

People

  1. Abou-Alfa
    Abou-Alfa
  2. Saltz
    Saltz
  3. O'Reilly
    O'Reilly
  4. Harding
    Harding
  5. Capanu
    Capanu
  6. Chou
    Chou
  7. Kemeny
    Kemeny
  8. Cercek Hanjis
    Cercek Hanjis
  9. Kelsen
    Kelsen
  10. Yu
    Yu

Groups

  1. Department of Medicine (28)
  2. Gastrointestinal Oncology Service (28)
  3. Solid Tumor Oncology Division (28)
  4. Center for Pancreatic Cancer Research (23)
  5. Epidemiology and Biostatistics (16)
  6. Biostatistics Service (14)
  7. Survivorship Research (11)
  8. Radiology, Department of (8)
  9. Body Imaging Service (6)
  10. GSK Faculty (5)
Search Within
  1. "Ghassan Abou-Alfa"
  2. "Leonard Saltz"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (3)
Groups
  1. Department of Medicine (28)
  2. Gastrointestinal Oncology Service (28)
  3. Solid Tumor Oncology Division (28)
  4. Center for Pancreatic Cancer Research (23)
  5. Epidemiology and Biostatistics (16)
  6. Biostatistics Service (14)

More Groups

People
  1. Ghassan Abou-Alfa (28)
  2. Leonard Saltz (28)
  3. Eileen O'Reilly (18)
  4. James Harding (14)
  5. Marinela Capanu (14)
  6. Maeve Lowery (11)

More People

Years
  1. 2017 (5)
  2. 2016 (3)
  3. 2015 (6)
  4. 2014 (6)
  5. 2013 (2)
  6. 2011 (2)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Journal of Oncology Practice (1)

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular carcinoma (HCC) and other gastrointestinal (GI) malignancies
    Meeting Abstract

    Harding, J. J.; Lowery, M. A.; Uhlitskykh, K.; Wan, P. J.; Hamilton, C. R.; Barba, A.; Liu, K. C. W.; Johnston, A.; Bomalaski, J. S.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Molecular landscape of fibrolamellar carcinoma (FLC): Beyond the DNAJB1-PRKACA chimera
    Meeting Abstract

    El Dika, I. H.; Capanu, M.; Berger, M. F.; Arcila, M. E.; Benayed, R.; Harding, J. J.; Rusek, M.; Valentino, E.; O'Reilly, E. M.; Saltz, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A situation where hepatocellular carcinoma (HCC) may be more common in women than men: Clinical and genetic patterns of non risk-factored HCC
    Meeting Abstract

    El Dika, I. H.; Harding, J. J.; Capanu, M.; Berger, M. F.; Rebibo, D.; Rusek, M.; Chou, J. F.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)
    Meeting Abstract

    Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma (HCC) and bone metastases (Mets)
    Meeting Abstract

    Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save